Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
If you are weighing all your options, start with our peptide safety guide
At six months, people taking GLP-1 drugs were: 26 percent more likely to develop nonscarring hair loss, an umbrella term for types of hair loss where the follicles are still intact and regrowth is possible 62 percent more likely to develop pattern hair thinning, such as thinning at the crown or widening of the part in women, or a receding hairline in men
Yes, when clinically appropriate and monitored
ASAP (days, not weeks): MEDVi, with 24 to 48 hour review and medication in 3 to 5 days
The clinical trials that produced the headline weight loss numbers all used 2.4 mg as the treatment dose
Retatrutide: Molecular Structure Chemical properties, amino acid sequence, and structural analysis TL;DR Molecular formula: C221H342N46O68 Molecular weight: 4731.41 Da Half-life: Approximately 6 days Amino Acid Sequence 69 amino acids Formula C221H342N46O68 Molecular Weight 4731.41 Da Half-Life Approximately 6 days Investigational Status Notice# Retatrutide (LY3437943) is an investigational compound developed by Eli Lilly and Company
US$ 29.31
US$ 28.13
US$ 25.59
US$ 25.02
US$ 27.94
